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Introduction {#sec1}
============

*Legionella pneumophila* is a Gram-negative bacterium found in fresh-water and soil environments [@bib1]. Human infection with *L. pneumophila* can cause legionellosis, which ranges from a mild, flu-like illness (Pontiac fever) to a severe and potentially fatal pneumonia (Legionnaires\' disease). The usual route of infection is via inhalation of aerosols from a contaminated environmental source [@bib2]. Commonly implicated sources include cooling towers, spa pools, decorative fountains, and water systems of large buildings.

When Legionnaires\' disease cases occur, clinical isolates are usually characterized together with epidemiologically linked environmental isolates to help determine the source of the infection. To date, most clinical microbiological laboratories have relied on analysing a single clinical isolate, or a small number of clinical isolates, from each patient. However, existence of within-host diversity of *L. pneumophila*, which has been poorly studied, would have important implications for the interpretation of molecular typing data. Here, we used sequence-based typing (SBT) [@bib3], [@bib4] together with whole-genome sequencing (WGS) to investigate the diversity amongst multiple colony picks recovered from individuals.

Methods {#sec2}
=======

Ten colony picks were obtained [@bib5] from single sputum samples of ten epidemiologically unrelated patients with sporadic Legionnaires\' disease in England ([Table 1](#tbl1){ref-type="table"}). Isolates were stored at --80°C. DNA was extracted after 48--72 hours of incubation on buffered charcoal yeast-extract agar at 37°C using the Wizard kit (Promega UK, Southampton, UK), eluted in 1 x Tris-EDTA buffer (pH 8.0), and quantified using GloMax (Promega, UK). SBT was undertaken as described previously [@bib3], [@bib4]. WGS was performed on Illumina X10 with 150-bp paired-end reads. Raw data were submitted to the European Nucleotide Archive (study accession number PRJEB12239/ERP013693). Individual accession numbers are provided in [Table 1](#tbl1){ref-type="table"}.Table 1Number and details of single-nucleotide polymorphisms (SNPs) identified amongst ten isolates recovered from each of ten Legionnaires\' disease patientsPatientAgeSexIsolation date (and number of days post infection onset that sample was obtained)Clinical informationEpidemiological informationSTReference genome (and size in bp)Length of reference genome mapped (bp)Range, mean and median number of SNPs between pairsSNP locations and geneAccession numbers179MJune 2015 (5)Admitted to ITUNosocomial case42EUL 120 (3,430,562) [@bib6]3,376,590--3,378,6100 SNPs between allERR1608296--ERR1608305255MMay 2015 (8)Not providedTravel-associated42EUL 120 (3,430,562) [@bib6]3,391,462--3,393,086Range 0--2, mean 0.4, median 0470,661 (*puuB*), 2,941,541 (*hemC*)ERR1608306--ERR1608315355MJune 2016 (5)Severe community-acquired pneumonia, diarrhoea, febrileTravel-associated (Caribbean and Spain)42EUL 120 (3,430,562) [@bib6]3,296,732--3,298,9090 SNPs between allERR2216341--ERR2216350471MApril 2016 (6)Admitted to ITUTravel-associated (Italy)23EUL 28 (3,509,586) [@bib6]3,369,571--3,371,1480 SNPs between allERR1608316-ERR1608325564MJune 2016 (3)Respiratory failureCommunity-acquired1Paris (3,635,495) [@bib10]3,436,622--3,438,632Range 0--1, mean 0.2, median 0418,832 (*lpp0256*)ERR2216351--ERR2216360666FSeptember 2016 (8)Admitted to ITUTravel-associated (Greece)37EUL 165 (3,474,638) [@bib6]3,332,884--3,334,1630 SNPs between allERR2216391--ERR2216400769MJuly 2016 (5)Admitted to ITU, pneumonia, sepsisTravel-associated20*De novo* assembly (3,560,463)3,544,455--3,545,2440 SNPs between allERR2216371--ERR2216380869MAugust 2016 (2)Admitted to ITU, sepsisCommunity-acquired477*De novo* assembly (3,307,866)3,291,099--3,292,328Range 0--1, mean 0.2, median 02,402,083 (intergenic)ERR2216381--ERR2216390975MSeptember 2016 (7)Not providedTravel-associated2287*De novo* assembly (3,344,279)3,328,536--3,329,7830 SNPs between allERR2216401--ERR22164101046MJuly 2016 (15)Not providedCommunity-acquired1522*De novo* assembly (3,621,967)3,589,885--3,591,537)0 SNPs between allERR2216361--ERR2216370[^1]

De novo assemblies were generated [@bib6], and MLSTcheck was used to confirm the sequence type (ST) from them [@bib7]---in particular ensuring that at least one of the *mompS* alleles matched that called by traditional SBT (since this gene is duplicated). Assemblies were annotated using Prokka v1.11 [@bib8].

Single-nucleotide polymorphisms (SNPs) were called for each isolate by mapping to a reference genome of the same ST using the Burrows--Wheeler aligner [@bib9]. Available reference genomes included ST1 (Paris), ST23 (EUL 28), ST37 (EUL 165) and ST42 (EUL 120) [@bib6], [@bib10]. For the rest (ST20, ST477, ST1522 and ST2287), de novo assemblies were used. A pipeline comprising SAMtools, mpileup and BCFtools was used to call SNPs [@bib11]. Various filters ensured high-accuracy base-calling, and bases were uncalled if any criteria were not fulfilled (reads matching base ≥4, reads matching base per strand ≥2, ratio of first to second base call ≥0.75, variant quality ≥50, mapping quality ≥30, strand bias ≥0.001, map bias ≥0.001, tail bias ≥0.001). SNPs identified in positions where the base was uncalled (i.e. 'n') in more than one isolate per patient were discarded.

To estimate the number of isolates that need to be analysed to observe all genotypes identified from a patient, random sampling of between one and ten isolates from each set of ten same-patient isolates was performed 100 times for each number of isolates without replacement.

Roary [@bib12] was used to determine gene content variation between isolates from the same patient. Pairs of assemblies were also aligned and compared using the 'dnadiff' tool (v1.3), which is part of the MUMmer package [@bib13].

Public Health England holds approvals to process patient-identifiable information for the purposes of infectious disease surveillance, in accordance with Section 60 of the Health and Social Care Act 2001. Ethical approval was not required for this study. The patient specimens were submitted for *Legionella* testing, including culture from microbiology laboratories in England. The *Legionella* data used is collated routinely by the Respiratory and Systemic Bacteria Section, Public Health England (PHE) as part of the national surveillance in England and Wales.

Results {#sec3}
=======

To investigate the within-host diversity of *L. pneumophila*, we first assessed the diversity of STs (as determined by SBT) amongst each set of ten isolates recovered from ten individual patients with sporadic Legionnaires\' disease. In each patient, all ten isolates had the same ST ([Table 1](#tbl1){ref-type="table"}).

The number of SNPs amongst same-patient isolates was then determined. The use of a closely related reference genome ensured that maximum resolution was achieved and that almost all SNP-based diversity amongst same-patient isolates would be captured. In seven out of ten patients, no SNPs were detected. In two patients, a maximum of one SNP was observed, and in one patient there was a maximum of two SNPs ([Table 1](#tbl1){ref-type="table"}). In each of these three sets in which diversity was observed, nine out of ten isolates were identical, and only one isolate differed by one or two SNPs.

Assuming that the full within-host SNP diversity in each set of ten same-patient isolates was captured, we performed random sampling of between one and ten isolates, and calculated the number of times that the full diversity was captured with that number of isolates. Since no SNPs were found amongst isolates from seven out of ten patients, the mean probability of capturing the full diversity with only one sample is 70%. This probability rises as the number of samples analysed increases and, on average, seven isolates are required to have a 90% chance of capturing all genotypes ([Fig. 1](#fig1){ref-type="fig"}).Fig. 1Boxplots showing the probability that all distinct genotypes found amongst each set of ten same-patient isolates are observed when between one and ten isolates are analysed. Probabilities were determined using 100 random samples without replacement for each number of isolates analysed. The blue circles represent the individual probabilities for each of the ten patients, and the red squares show the mean across all ten patients.

Finally, we investigated the extent of gene content variation between isolates from the same patient. We found no evidence of variation in gene content except for small differences introduced by assembly artefacts.

Discussion {#sec4}
==========

This study provides the most comprehensive analysis of within-host diversity of *L. pneumophila* in Legionnaires\' disease patients to date. The results demonstrate either no or very low within-host diversity in ten patients. We also show that, on average, analysis of one isolate provides a 70% chance of capturing all within-host variation found with ten isolates. Very low within-host diversity has also been observed previously [@bib6], [@bib14], albeit with lower numbers of isolates and patients. Others have reported the opposite, including Coscolla et al. [@bib15] who reported mixed infections in several patients based on SBT profiles from uncultured respiratory samples. Another study that used WGS identified two same-patient isolates belonging to distinct ST191 subtypes that differed by approximately 20 SNPs [@bib16]. However, multiple isolates from three other patients in the same study were identical. Thus, while our study suggests that very low within-host diversity is the norm (at least in sporadic infections), greater diversity has occasionally been observed. Indeed, within-host diversity likely depends on several environmental, clinical and epidemiological factors, including the diversity of *L. pneumophila* in environmental sources, variation in infectious dose between patients, and the duration of infection prior to sampling.

A significant limitation to our study is that the use of culturing procedures may favour growth of some strains over others, thereby reducing the observed diversity. Furthermore, because of the collection of isolates from a single time point, as well as the reliance on culture, it is not possible to determine whether the observed diversity was present at the start of the infection, or whether it evolved during the infection or subsequently in culture. We propose that these limitations may be overcome in future studies by the use of metagenomics on multiple samples obtained over time from the same patient.
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[^1]: ST, sequence type; bp, base pair; ITU, intensive therapy unit.
